New vaccine could stop recurring yeast infections in women

NCT ID NCT06190509

Ongoing ⭐️ VACCINE ⭐️ Sponsor: LimmaTech Biologics AG Source: ClinicalTrials.gov ↗

First seen Sep 30, 2025 · Last updated May 24, 2026 · Updated 30 times

Summary

This study tests a new vaccine called Candi5V in women who get frequent yeast infections (at least 3 per year). The goal is to see if the vaccine is safe and helps the body build immunity against the fungus that causes these infections. About 251 women will receive either the vaccine or a placebo, and researchers will monitor side effects and immune responses over several months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT VULVOVAGINAL CANDIDIASIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Aidport sp.z o.o.

Skórzewo, Poznan, 60-185, Poland
Femicare

Tienen, Tienen, 3300, Belgium
IN-VIVO Sp. z o.o.

Bydgoszcz, 85-048, Poland
MTZ Clinical Research powered by Pratia

Warsaw, 02-172, Poland
NZOZ Medem

Katowice, 40-301, Poland
Universitair Ziekenhuis Gent

Ghent, 9000, Belgium
Velocity Nova sp. z o.o

Lublin, 20-362, Poland

Conditions

Explore the condition pages connected to this study.

RECURRENT VULVOVAGINAL CANDIDIASIS